These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 21418025

  • 1. Bowman-Birk inhibitors from legumes and human gastrointestinal health: current status and perspectives.
    Clemente A, Sonnante G, Domoney C.
    Curr Protein Pept Sci; 2011 Aug; 12(5):358-73. PubMed ID: 21418025
    [Abstract] [Full Text] [Related]

  • 2. Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents.
    Clemente A, Arques Mdel C.
    World J Gastroenterol; 2014 Aug 14; 20(30):10305-15. PubMed ID: 25132747
    [Abstract] [Full Text] [Related]

  • 3. Biological significance of polymorphism in legume protease inhibitors from the Bowman-Birk family.
    Clementea A, Domoney C.
    Curr Protein Pept Sci; 2006 Jun 14; 7(3):201-16. PubMed ID: 16787260
    [Abstract] [Full Text] [Related]

  • 4. The anti-proliferative effect of TI1B, a major Bowman-Birk isoinhibitor from pea (Pisum sativum L.), on HT29 colon cancer cells is mediated through protease inhibition.
    Clemente A, Carmen Marín-Manzano M, Jiménez E, Carmen Arques M, Domoney C.
    Br J Nutr; 2012 Aug 14; 108 Suppl 1():S135-44. PubMed ID: 22916809
    [Abstract] [Full Text] [Related]

  • 5. The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases.
    Clemente A, Moreno FJ, Marín-Manzano Mdel C, Jiménez E, Domoney C.
    Mol Nutr Food Res; 2010 Mar 14; 54(3):396-405. PubMed ID: 19885848
    [Abstract] [Full Text] [Related]

  • 6. Lathyrus sativus Originating from Different Geographical Regions Reveals Striking Differences in Kunitz and Bowman-Birk Inhibitor Activities.
    Xu Q, Qu J, Song B, Liu F, Chen P, Krishnan HB.
    J Agric Food Chem; 2019 Jul 24; 67(29):8119-8129. PubMed ID: 31265283
    [Abstract] [Full Text] [Related]

  • 7. Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
    Safavi F, Rostami A.
    Exp Mol Pathol; 2012 Dec 24; 93(3):428-33. PubMed ID: 23022357
    [Abstract] [Full Text] [Related]

  • 8. Evidence that the Bowman-Birk inhibitor from Pisum sativum affects intestinal proteolytic activities in chickens.
    Moreau T, Recoules E, De Pauw M, Labas V, Réhault-Godbert S.
    Poult Sci; 2024 Jan 24; 103(1):103182. PubMed ID: 37931399
    [Abstract] [Full Text] [Related]

  • 9. Anti-carcinogenic soyabean Bowman-Birk inhibitors survive faecal fermentation in their active form and do not affect the microbiota composition in vitro.
    Marín-Manzano MC, Ruiz R, Jiménez E, Rubio LA, Clemente A.
    Br J Nutr; 2009 Apr 24; 101(7):967-71. PubMed ID: 19353764
    [Abstract] [Full Text] [Related]

  • 10. The biochemical and functional food properties of the bowman-birk inhibitor.
    Losso JN.
    Crit Rev Food Sci Nutr; 2008 Jan 24; 48(1):94-118. PubMed ID: 18274967
    [Abstract] [Full Text] [Related]

  • 11. Protease Inhibitors from Plants as Therapeutic Agents- A Review.
    Cid-Gallegos MS, Corzo-Ríos LJ, Jiménez-Martínez C, Sánchez-Chino XM.
    Plant Foods Hum Nutr; 2022 Mar 24; 77(1):20-29. PubMed ID: 35000105
    [Abstract] [Full Text] [Related]

  • 12. Bowman-Birk protease inhibitor from the seeds of Vigna unguiculata forms a highly stable dimeric structure.
    Rao KN, Suresh CG.
    Biochim Biophys Acta; 2007 Oct 24; 1774(10):1264-73. PubMed ID: 17869196
    [Abstract] [Full Text] [Related]

  • 13. Immunoconjugates of soybean Bowman-Birk protease inhibitor as targeted antitumor polymeric agents.
    Gladysheva IP, Moroz NA, Karmakova TA, Nemtsova ER, Yakubovskaya RI, Larionova NI.
    J Drug Target; 2001 Oct 24; 9(5):303-16. PubMed ID: 11770701
    [Abstract] [Full Text] [Related]

  • 14. Proteases, protease inhibitors and radiation carcinogenesis.
    Kennedy AR.
    Int J Radiat Biol; 2023 Oct 24; 99(6):882-890. PubMed ID: 34325613
    [Abstract] [Full Text] [Related]

  • 15. Radioprotection of normal tissue to improve radiotherapy: the effect of the Bowman Birk protease inhibitor.
    Dittmann KH, Mayer C, Rodemann HP.
    Curr Med Chem Anticancer Agents; 2003 Sep 24; 3(5):360-3. PubMed ID: 12871082
    [Abstract] [Full Text] [Related]

  • 16. The protective role of the Bowman-Birk protease inhibitor in soybean lunasin digestion: the effect of released peptides on colon cancer growth.
    Cruz-Huerta E, Fernández-Tomé S, Arques MC, Amigo L, Recio I, Clemente A, Hernández-Ledesma B.
    Food Funct; 2015 Aug 24; 6(8):2626-35. PubMed ID: 26132418
    [Abstract] [Full Text] [Related]

  • 17. Extensive structural variation in the Bowman-Birk inhibitor family in common wheat (Triticum aestivum L.).
    Xie Y, Ravet K, Pearce S.
    BMC Genomics; 2021 Mar 25; 22(1):218. PubMed ID: 33765923
    [Abstract] [Full Text] [Related]

  • 18. Chemopreventive agents: protease inhibitors.
    Kennedy AR.
    Pharmacol Ther; 1998 Jun 25; 78(3):167-209. PubMed ID: 9690817
    [Abstract] [Full Text] [Related]

  • 19. A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor.
    Billings PC, Habres JM.
    Proc Natl Acad Sci U S A; 1992 Apr 01; 89(7):3120-4. PubMed ID: 1557421
    [Abstract] [Full Text] [Related]

  • 20. Quantitative determination of active Bowman-Birk isoinhibitors, IBB1 and IBBD2, in commercial soymilks.
    Arques MC, Marín-Manzano MC, da Rocha LC, Hernandez-Ledesma B, Recio I, Clemente A.
    Food Chem; 2014 Jul 15; 155():24-30. PubMed ID: 24594149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.